Returned medicines in community pharmacies of Barcelona, Spain
- 326 Downloads
Objective To monitor the amount of unused drugs and the cost to the public health system. Setting A random sample of community pharmacies in Barcelona, Spain. Method The drugs were collected from 38 community pharmacies over a period of 7 consecutive working days (excluding Sundays). A questionnaire was designed to evaluate each returned medicine. The resulting data were analyzed and evaluated. Main outcome measure The number of drugs collected at the pharmacy, the characteristics of the clients and the reasons why they returned the drugs, and finally the economic value of the drugs returned and the cost to the public health system. Results A total of 227 clients (54.6% women, 64 ± 20 years-old) returned 1,176 packages to the pharmacy. The number of packages collected in one return ranged from 1 to 121. The number of packages collected per pharmacy ranged from 0 to 188. In more than half of the cases (52.4%) the patients returned their drug in person and in 32.2% of the cases a relative returned it on their behalf. The main reason (28.2%) why drugs were returned was the expiry date. In 24.9% of the cases the patient's condition had improved and there was no further need for the drug. In 20.8% the patient had died. The estimated total cost of the collected drugs was €8,539.9. Over 75% of this amount (€6,463.9) had been paid by the public health system. Conclusion This study confirms the importance of analyzing the return of unwanted medicines to reduce unnecessary health expenditure. It also highlights the inadequacies of the Spanish health system in the areas of prescription, dispensing and use of medicines. Establishing strategies to reduce the wastage of unused medicines is necessary.
KeywordsCommunity pharmacy Drug expenditure Medicine waste Returned medicine Spain Unused drug
We would like to sincerely thank the following community pharmacies of Barcelona: Albà, Alomar, Arranz, Balanyà, Bregante, Buil, Carbonell, Casalà, Castellvi, Cava, Ciurana, De Frutos, Donada, Escudero, Fiol, Flores, Frisch, Gibert-Paris, Gil, Herrero, Laporte, Mandianes, Mas, Massegué, Mesia, Mugueta, Olivart, Olivé, Puig, Rodríguez-Alsina, Rull, Sardar, Segura, Serra, Taberner, Tarrés, Veciana, Vives-Ferrer for their voluntary participation in this study.
- 1.Observatorio SNS. Informe anual del Sistema Nacional de Salud 2003. Madrid: Ministerio de Sanidad y Consumo, 2004. http://www.msc.es/organizacion/sns/informeAnualSNS/home.htm (last accessed 24 October 2006).
- 3.Marchiset N, Gerbaud L, Sauvant M-P, Jaffeux P, Mnhes G, Leblanc N, et al. Description des Médicaments Non Utilisés (MNU) collectés dans les pharmacies du Puy de Dome. Rev d’Epidémiol Sante Publique. 2001;49(6):551–8.Google Scholar
- 4.Ballu O. Statut des médicaments non utilisés (MNU). France: École Nationale de la Santé Publique (ENSP), Rennes; 2003. (ISBN 002B30A11).Google Scholar
- 5.Sistema Integrado de Gestión y Recogida de Envases (SIGRE). http://www.sigre.es/inicio.asp (last accessed 24 October 2006).
- 6.Braybrook S, John DN, Leong K. A survey of why medicines are returned to pharmacies. Pharm J. 1999;263:7063.Google Scholar
- 7.Grant P. Return of waste medicines to a community pharmacy. Prescriber 2001;12(4):29–38.Google Scholar
- 10.WHO. ATC/DDD Index. http://www.whocc.no/atcddd (last accessed 15 September 2006).
- 11.Cameron S. Study by Alberta pharmacists indicates drug wastage a “mammoth” problem. Can Med Assoc J. 1996;155(11):1596–8.Google Scholar
- 14.Ekedahl A, Wergeman L, Rydberg T. Unused drugs in Sweden measured by returns to pharmacies. J Soc-Adm-Pharm. 2003;20(1):26–31.Google Scholar
- 15.Anonym. Indicadores de la prestación farmacéutica del SNS a través de receta. Año 2003-Medidas de Farmacovigilancia. Inf Ter Sist Nac Salud. 2004;28(5):128.Google Scholar
- 16.Bouvy M, Coma A, Mariño EL, Modamio P. European survey about unused drugs. Pharm World Sci. 2005;27:A79.Google Scholar
- 17.Organization for Economic Co-operation and Development (OCDE). OCDE Health Data 2004. http://www.oecd.org/dataoecd/60/25/31819753.pdf (last accessed 15 September 2006).
- 18.Cromarty E, Downie G. Drug wastage—what is acceptable? Pharm J. 2001;267(7167):424.Google Scholar
- 19.Longmore RB, Sunderland VB, Sansom LN. Analysis of a “Medidump” campaign in Australia. Int J Pharm Pract. 1995;3:186–91.Google Scholar
- 21.Smith CA. Managing pharmaceutical waste: what pharmacists should know. J Pharm Soc Wisc. 2002; Nov/Dec:17–22.Google Scholar